1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with glucosamine in 6 studies
| Studies (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Trials (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Recent Studies (post-2010) (1-hexadecyl-2-acetyl-glycero-3-phosphocholine) | Studies (glucosamine) | Trials (glucosamine) | Recent Studies (post-2010) (glucosamine) |
|---|---|---|---|---|---|
| 9,156 | 187 | 552 | 10,273 | 280 | 1,467 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 2 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ikeda, K; Sasaki, H; Sasaki, T; Shimura, S; Takishima, T | 1 |
| Eliakim, R; Karmeli, F; Rachmilewitz, D; Razin, E | 1 |
| Armarego, WL; Kosar-Hashemi, B; Taguchi, H | 1 |
| Slomiany, A; Slomiany, BL | 1 |
| Bate, C; Tayebi, M; Williams, A | 1 |
| Bae, JH; Im, SS; Jang, BC; Kim, JN; Park, JH; Song, DK | 1 |
6 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and glucosamine
| Article | Year |
|---|---|
Platelet-activating factor increases platelet-dependent glycoconjugate secretion from tracheal submucosal gland.
Topics: Animals; Blood Platelets; Bridged Bicyclo Compounds, Heterocyclic; Cats; Fatty Acids, Unsaturated; Glucosamine; Glycoconjugates; Hydrazines; In Vitro Techniques; Indomethacin; Kinetics; Methysergide; Mucous Membrane; Phospholipid Ethers; Platelet Activating Factor; Radioisotope Dilution Technique; Thromboxane A2; Trachea; Tritium | 1989 |
Role of platelet-activating factor in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine and prednisolone.
Topics: Adult; Aminosalicylic Acids; Calcimycin; Colitis, Ulcerative; Colon; Drug Combinations; Female; Glucosamine; Humans; Immunoglobulin E; Intestinal Mucosa; Male; Middle Aged; Platelet Activating Factor; Prednisolone; Rectum; Sulfapyridine; Sulfasalazine | 1988 |
Glyceryl ether monooxygenase [EC 1.14.16.5]: stoichiometry and inhibition.
Topics: Fatty Acids; Glucosamine; Glyceryl Ethers; Indicators and Reagents; Kinetics; Mixed Function Oxygenases; Platelet Activating Factor; Pterins | 1993 |
Platelet-activating factor mediates Porphyromonas gingivalis lipopolysaccharide interference with salivary mucin synthesis via phosphatidylinositol 3-kinase-dependent constitutive nitric-oxide synthase activation.
Topics: Amidines; Androstadienes; Animals; Apoptosis; Benzylamines; Cell Survival; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Ginkgolides; Glucosamine; Lactones; Lipopolysaccharides; Mucins; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Activating Factor; Porphyromonas gingivalis; Rats; Rats, Sprague-Dawley; Saliva; Salivary Glands; Sublingual Gland; Tritium; Tumor Necrosis Factor-alpha; Up-Regulation; Wortmannin | 2004 |
Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
Topics: Animals; Cell Line; Cell Membrane; Cholesterol; Extracellular Space; Glucosamine; Glycosylphosphatidylinositols; Mice; Phospholipases A2; Platelet Activating Factor; PrPC Proteins; PrPSc Proteins | 2010 |
Glucosamine suppresses platelet-activating factor-induced activation of microglia through inhibition of store-operated calcium influx.
Topics: Calcium; Calcium Signaling; Calcium, Dietary; Cells, Cultured; Cyclooxygenase 2; Glucosamine; Humans; Microglia; Platelet Activating Factor | 2016 |